Testing effectiveness (Phase 2)Study completedNCT01334515
What this trial is testing
Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
Who this might be right for
Recurrent Neuroblastoma
Children's Oncology Group 52